Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Finished Goods (2022 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Finished Goods for 4 consecutive years, with $518209.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods fell 41.11% year-over-year to $518209.0, compared with a TTM value of $518209.0 through Dec 2025, down 41.11%, and an annual FY2025 reading of $1.2 million, down 21.75% over the prior year.
  • Finished Goods was $518209.0 for Q4 2025 at Neuroone Medical Technologies, down from $1.2 million in the prior quarter.
  • Across five years, Finished Goods topped out at $1.6 million in Q3 2024 and bottomed at $73968.0 in Q3 2022.
  • Average Finished Goods over 4 years is $718677.7, with a median of $703302.0 recorded in 2024.
  • The sharpest move saw Finished Goods surged 388.62% in 2024, then crashed 41.11% in 2025.
  • Year by year, Finished Goods stood at $73968.0 in 2022, then surged by 143.47% to $180092.0 in 2023, then soared by 388.62% to $879966.0 in 2024, then plummeted by 41.11% to $518209.0 in 2025.
  • Business Quant data shows Finished Goods for NMTC at $518209.0 in Q4 2025, $1.2 million in Q3 2025, and $775950.0 in Q2 2025.